Publications by authors named "G W CARTER"

Triple-negative breast cancers (TNBCs) are invasive carcinomas that lack ER and PR expression and also lack amplification or overexpression of HER2. Triple-negative breast cancers are histopathologically diverse, with the majority classified as invasive breast carcinomas of no special type with a basal-like profile. Triple-negative breast cancer is the most aggressive molecular subtype of invasive breast carcinoma, with the highest rates of stage-matched mortality and regional recurrence.

View Article and Find Full Text PDF

Background: Anxiety disorders and treatment-resistant major depressive disorder (TRD) are often comorbid. Studies suggest ketamine has anxiolytic and antidepressant properties.

Aims: To investigate if subcutaneous racemic ketamine, delivered twice weekly for 4 weeks, reduces anxiety in people with TRD.

View Article and Find Full Text PDF

Background: Stigma significantly impacts individuals with Parkinson's disease (PD) and their caregivers, exacerbating social isolation, psychological distress, and reducing quality of life (QoL). Although considerable research has been conducted on PD's clinical aspects, the social and emotional challenges, like stigma, remain underexplored. Addressing stigma is crucial for enhancing well-being, fostering inclusivity and improving access to care and support.

View Article and Find Full Text PDF
Article Synopsis
  • ALSUntangled examines alternative treatments for ALS, focusing on psilocybin, a psychedelic compound from mushrooms.
  • Psilocybin may theoretically help slow ALS due to its ability to cross the blood-brain barrier and influence neurogenesis and inflammation, but there's no existing research specifically on its effects in ALS patients.
  • Due to potential risks of psychological side effects and lack of supporting evidence, the use of psilocybin for ALS progression is not currently endorsed.
View Article and Find Full Text PDF

Background: U.S. policy intervention to increase methadone treatment accommodations during COVID did not result in national adoption of the new patient-centered treatment practices.

View Article and Find Full Text PDF